A measure of limited joint motion and deformity correlates with HLA-DRB1 and DQB1 alleles in patients with rheumatoid arthritis

Annals of the Rheumatic Diseases

Volumn 58, Issue 11, 1999, Pages 703-708

  Cranney, Ann ^c   Goldstein, Rose ^c   Ba'Pham, ^c   Newkirk, Marianna M ^a   Karsh, Jacob ^b  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HLA DR ANTIGEN; RHEUMATOID FACTOR;

ALLELE; ARTHROPATHY; ARTICLE; DISEASE COURSE; DISEASE DURATION; DISEASE PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; JOINT MOBILITY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

EID: 0032746519     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.58.11.703     Document Type: Article

References (48)

1. Duthic JJR, Brown PE, Truelove LH, Baragar FD, Lawrie AJ. Course and prognosis in rheumatoid arthritis. Ann Rheum Dis 1964;23:193-202.
2. Sherrer YS, Bloch DA, Mitchell DM, Young DY, Fries JF. The development of disability in rheumatoid arthritis. Arthritis Rheum 1986;29:494-500.
3. Pincus T, Callahan LF, Sale WG, Brooks AC, Payne LE, Vaughn WK. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum 1984;27:864-72.
4. Thould AK, Simon G. Assessment of radiological changes in the hands and feet in rheumatoid arthritis: their correlation with prognosis. Ann Rheum Dis 1966;25:220-8.
5. Brook A, Corbett M, Radiographic changes in early rheumatoid disease. Ann Rheum Dis 1977;36:71-3.
6. Scoti DL, Coulton BL, Bacon PA, Popert AJ. Methods of X-ray assessment in rheumatoid arthritis: A re-evaluation. Br J Rheumatol 1985;24:31-9.
7. Fuchs HA, Kaye JJ, Callahan LF, Nance EP, Pincus T. Evidence of significant radiographic damage in rheumatoid arthritis within the first two years of disease. J Rheumatol 1989;16:585-91.
8. Fuchs HA, Pincus T. Radiographic damage in rheumatoid arthritis: description by non-linear models. J Rheumatol 1992;19:1655-8.
9. Larsen A, Thoen J. Hand radiography of 200 patients with rheumatoid arthritis repeated after a interval of one year. Scand J Rheumatol 1987;16:395-401.
10. Wolfe F, Cathey MA. The assessment and prediction of functional disability in rheumatoid arthritis. J Rheumatol 1991;18:12981306.
11. Pincus T, Wolfe F, Callaban LF. Updating a reassessment of traditional paradigms concerning rheumatoid arthritis. In: Wolfe F, Pincus T, eds. Rheumatoid arthritis: pathogenesis, assessment, outcome, and treatment. New York: Marcel Dekker, 1994:1-74.
12. Suarez-Almazor ME, Soskolne CL, Saunders D, Russell AS. Outcome in rheumatoid arthritis. A 1985 inception cohort study. J Rheumatol 1994;21:1438-46.
13. Brennan P, Harrison B, Barrett E, Chakravarty K, Scott D, Silman A, et al. A simple algorithm to predict the development of radiological erosions in patients with early rheumatoid arthritis:prospective cohort study. BMJ 1996;313:471-6.
14. Gough A, Faint J, Salmon M, Hassel A, Wordsworth P, Pilling D, et al. Genetic typing of patients with inflammatory arthritis at presentation can he used to predict outcome. Arthritis Rheum 1994;37:1166-70.
15. Devlin J, Gough A, Huissoon A, Perkins P, Holder R, Reece R, et al. The acute phase and function in early rheumatoid arthritis. C-reactive protein levels correlate with functional outcome. J Rheumatol 1997;24:9-13.
16. van Leeuwen MA, van Rijswijk MH, Sliuter WJ, van Riel PLCM, Kuper IH, van de Putte LBA, et al. Individual relationship between progression of radiological damage and the acute phase response in early rheumatoid arthritis. Towards development of a decision support system. J Rheumatol 1997;24:20-7.
17. Coste J, Spira A, Clerc D, Paologgi J-B. Prediction of articular destruction in rheumatoid arthritis: Disease activity markers revisited. J Rheumatol 1997;24:28-34.
18. Munro R, Capell H. C-reactive protein levels correlate with functional outcome. J Rheumatol 1997;24:1852-3.
19. Otterness IG. The value of C-reactive protein measurement in rheumatoid arthritis. Semin Arthritis Rheum 1994;24:91-104.
20. Hassell AB, Plant MJ, Clark S, Fisher J, Jones DW, Saklatvala J, et al. Small joint synovitis in rheumatoid arthritis: Should it be assessed seperately? Br J Rheumatol 1995;34:51-5.
21. Boki KA, Panayi GS, Vaughan RW, Drosos AA, Moutsopoulos HM, Lanchbury JS. HLA Class II sequence polymorphisms and susceptibility to rheumatoid arthritis in Greeks. Arthritis Rheum 1992;35:749-55.
22. Nepom GT, Nepom Nepom BS. Prediction of susceptibility to rheumatoid arthritis by human leukocyte antigen genotyping. Rheum Dis Clin North Am 1992;18:785-92.
23. Toda Y, Minamikawa Y, Akagi S, Sugano H, Mori Y, Nishimura H, et al. Rheumatoid susceptibility alleles of HLA-DRB1 are genetically recessive to non-suscceptible alleles in the progression of bone destruction in the wrists and fingers of patients with RA. Ann Rheum Dis 1994;53:587-92.
24. Jawaheer D, Thomson W, MacGregor AJ, Carthy D, Davidson J, Dyer PA, et al. "Homozygosity" for the HLA-DR shared epitope contributes the highest risk for rheumatoid arthritis concordance in identical twins. Arthritis Rheum 1994;37;681-6.
25. Weyand CM, McCarthy TG, Goronzy JJ. Correlation between disease phonotype and genetic heterogeneity in rheumatoid arthritis. J Clin Invest 1995;95:2120-6.
26. Reveille JD, Alarcon GS, Fowler SE, Pillemer SR, Neuner R, Clegg DO, et al. HLA-DRB1 genes and disease severity in rheumatoid arthritis. Arthritis Rheum 1996;39:1802-7.
27. Wagner U, Kaltenhauser S, Sauer H, Arnold S, Seidel W, Hantzschel JR, et al. HLA markers and prediction of clinical course and outcome in rheumatoid arthritis. Arthritis Rheum 1997;40; 341-51.
28. Perdriger A, Chales G, Semana G, Guggenbuhl P, Meyer O, Quillivic F, et al. Role of HLA-DR-DR associations in the expression of extraarticular manifestations and rheumatoid factor in rheumatoid arthritis. J Rheumatol 1997;24: 1272-6.
29. Suarez-Almazor ME, Tao, S, Moustarah F, Russell AS, Maksymowych W. HLA-DR1, DR4, and DRB1 disease related subtypes in rheumatoid arthritis. Association and susceptibility but not severity in a city wide community based study. J Rheumatol 1995;22:2027-33.
30. Salaffi F, Ferracioli GF. Progress of the anatomical damage in rheumatoid hands. Radiography of the natural course of the disease or of the course during treatment? Scand J Rheumatol 1989;18:119-20.
31. Pincus T, Larsen A, Brooks RH, Kaye J, Nance EP, Callahan LF. Comparison of 3 quantitative measures of hand radiographs in patients with rheumatoid arthritis: Steinbrocker Stage, Kayo modified Sharp score, and Larsen score. J Rheumatol 1997;24:2106-12.
32. Pincus T. Why should rheumatologists collect patient self-report questionnaires in routine rheumatologic care? Rheum Dis Clin North America 1995;21:271-319.
33. Griffiths B, Situnayake RD, Emery P. Altered damage function relationships in different racial groups with rheumatoid arthritis. [Abstract]. Arthritis Rheum 1997;40:S155.
34. Pincus T. Assessment of long term outcomes in rheumatoid arthritis. Rheum Dis Clin North Am 1995;21:619-54.
35. Spiegel TM, Spiegel JN, Paulus HE. The joint alignment and motion scale: A simple measure of joint deformity in patients with rheumatoid arthritis. J Rheumatol 1987;14: 887-92.
36. Ferraz MB, Oliviera LM, Araujo PMP, Atra E, Walter SD. EPM-ROM scale: an evaluative instrument to be used in rheumatoid arthritis trials. Clin Exp Rheumatol 1990;8:491-4.
37. American Rheumatism Association. Dictionary of the rheumatic diseases. Vol I. New York: Contact Associates International, 1982;77.
38. Gustincich S, Manfiolett G, Del Sal G, Schneider C, Carninci P. A fast method for quality genomic DNA extraction from whole human blood. Biotechniques 1991;11:298-302.
39. Myers RH. Classical and modern regression with applications. Boston: Duxbury Press, 1986.
40. Greenland S. Dose-response and trend analysis in epidemiology: alternatives categorical analysis. Epidemiology 1995;6:356-65.
41. Brenner H, Blettner M. Controlling for continuous confounders in epidemiologic research. Epidemiology 1997;8:429-34.
42. Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. JAMA 1949;140:659-62.
43. Larsen A, Dale K, Eek M, Pahle J. Radiographic evaluation of rheumatoid arthritis by standard reference films. J Hand Surg 1983;8:667-9.
44. Sharp JT. Radiographic evaluation of the course of articular disease. Clin Rheum Dis 1983;9:541-7.
45. van der Heijde DMFM, van Riel PLCM, van Leeuwen MA, van't Hof MA, van Rijswijk MH, van de Puree LBA. Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis. A prospective follow up study of 147 patients. Br J Rheumatol 1992;31:519-25.
46. van der Heidje DMFM, van't Hof MA, van Rid PLCM, van Leeuwen MA, van Rijswijk MH, van der Putte LBA. Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis. Ann Rheum Dis 1992;51:177-81.
47. Weyand C, Xie C, Goronzy JJ. Homozygosity for the HLA-DPB1 alleles selects for extraarticular manifestations in rheumatoid arthritis. J Clin Invest 1992;89:2033-9.
48. Singal DP, Green D, Reid B, Gladman DD, Buchanan WW. HLA-D region genes and rheumatoid arthritis: importance of DR and DQ genes in conferring susceptibility to RA. Ann Rheum Dis 1992;51:23-8.